The Westin Arlington

2025年4月07日 (月) 午前 7:00 - 2025年4月08日 (火) 午後 4:00

801 N. Glebe Road, Arlington, VA 22203, USA

Global Labeling Conference

Join speakers from around the world sharing their labeling expertise!

Registration Ends

21

DAYS

21

HOURS

24

MINUTES

58

SECONDS

Session 8: Will Artificial Intelligence (AI) Transform Drug Labeling Processes?

Session Chair(s)

Deborah  Bebbington

Deborah Bebbington

Head Global Labeling

Bayer Plc, United Kingdom

Mary Beth  Wilusz

Mary Beth Wilusz

Head, Regulatory Labeling Operations and Compliance

Daiichi Sankyo, Inc., United States

This session will examine the transformative role of artificial intelligence (AI), neuro linguistic programming (NLP), and machine learning (ML) in global regulatory labeling, highlighting opportunities to enhance efficiency, accuracy, and compliance. Speakers will discuss how these technologies can streamline processes, from automating label updates to analyzing health authority requirements, while addressing challenges such as integration and data privacy. Attendees will gain insights into how AI-driven innovations are reshaping labeling processes, future directions in the industry, and strategies for collaborating with health authorities to navigate the evolving regulatory landscape.

Learning Objective :
  • Describe how to structure prompts to generate appropriate AI output
  • Identify specific areas of the labeling process that can benefit from the use AI, NLP or ML
  • Evaluate the future role and potential of AI in the regulatory labeling landscape

Speaker(s)

Irene  Kuhlman, MSc

Speaker

Irene Kuhlman, MSc

Bayer Pharma NL, Netherlands

Global Labeling Strategist

Mike  DeMarco, PharmD

Speaker

Mike DeMarco, PharmD

PwC, United States

Director, Clinical Transformation R&D Managment Consulting

Michelle  Wu, MBA

Speaker

Michelle Wu, MBA

NyquistAI, United States

Co-founder & CEO

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。